26. Saccharopolyspora Erythraea: Respiratory Infection Fighter
Scientists isolated erythromycin from this bacterium in 1952. It treats gram-positive bacterial infections, particularly in penicillin-allergic patients. Researchers later developed azithromycin, a modified version with a longer half-life requiring less frequent dosing. These antibiotics work by preventing bacteria from making essential proteins. Their widespread use against respiratory infections has unfortunately contributed to resistance problems. However, they remain valuable treatment options when prescribed appropriately.